Preboj raka jeter - vitamin C prednostno ubije matične celice raka jeter

Deli to objavo

At the end of 2015, science research claimed that high doses of vitamin C (about the equivalent of 300 oranges) can effectively kill colon cancer cells that carry a common carcinogenic mutation (KRAS and BRAF).

In March 2017, “Cancer Cell” magazine confirmed that it is safe to regularly inject 800-1000 times the recommended daily dose of vitamin C in patients with brain and lung cancer, and it can change iron metabolism and cause specific DNA damage in cancer cells. Cause cell death and achieve effective treatment of cancer.

In August of the same year, it was demonstrated in the journals “Cell” and “Nature” that vitamin C can control the occurrence of hematological tumors and reverse leukemia by activating the activity of an epigenetic modification enzyme (TET2).

At the beginning of 2018, in the “Npj-Precision Medical Oncology” sub-journal of Nature, the research team of Academician Wang Hongyang from the Eastern Hepatobiliary Surgery Hospital of the Naval Military Medical University brought exciting research progress- vitamin C “priority” killing Cancer stem cells of liver cancer and improve the prognosis of patients .

However, only the high dose of vitamin C in the blood obtained through “intravenous administration” has been researched and confirmed to have an anti-cancer effect, and it is not achieved by “eating” oranges or vitamin C tablets. When we get too much vitamin C from the diet, the body will excrete excess vitamin C through the urine. Seeing this, did you silently put down the orange that was hard to put in your mouth? So please don’t blindly add vitamin C, because it is useless and wastes money.

Although research has confirmed that injecting vitamin C can help fight liver cancer tumors, do not blindly supplement vitamin C, do not need to eat too many fruits rich in vitamin C, and do n’t use the results of the above research stage as a basis, Note: “Vitamin C should listen to the clinician’s advice.

Naročite se na naše e-novice

Pridobite posodobitve in nikoli ne zamudite bloga Cancerfax

Več V Razišči

Vloga reševalcev pri uspehu CAR T celične terapije
CAR T-celična terapija

Vloga reševalcev pri uspehu CAR T celične terapije

Bolničarji igrajo ključno vlogo pri uspehu terapije T-celic CAR z zagotavljanjem brezhibne oskrbe pacientov skozi celoten proces zdravljenja. Zagotavljajo nujno podporo med transportom, spremljajo vitalne znake pacientov in izvajajo nujne medicinske posege, če pride do zapletov. Njihov hiter odziv in strokovna oskrba prispevata k splošni varnosti in učinkovitosti terapije, omogočata bolj gladke prehode med zdravstvenimi ustanovami in izboljšujeta rezultate bolnikov v zahtevnem okolju naprednih celičnih terapij.

Rabim pomoč? Naša ekipa vam je pripravljena pomagati.

Želimo vam hitro okrevanje vašega dragega in bližnjega.

Začni klepet
Smo na spletu! Klepetajte z nami!
Skenirajte kodo
Zdravo,

Dobrodošli na CancerFax!

CancerFax je pionirska platforma, namenjena povezovanju posameznikov, ki se soočajo z napredovalim stadijem raka, z revolucionarnimi celičnimi terapijami, kot je CAR T-Cell terapija, TIL terapija in kliničnimi preskušanji po vsem svetu.

Sporočite nam, kaj lahko storimo za vas.

1) Zdravljenje raka v tujini?
2) CAR T-celična terapija
3) Cepivo proti raku
4) Spletno video posvetovanje
5) Protonska terapija